Brentuximab vedotin in combination with CHP in patients (pts) with newly-diagnosed CD30+ peripheral T-cell lymphomas (PTCL): 2-year follow-up Meeting Abstract
| Authors: | Fanale, M. A.; Horwitz, S. M.; Forero-Torres, A.; Bartlett, N. L.; Advani, R. H.; Pro, B.; Chen, R. W.; Davies, A.; Illidge, T.; Huebner, D.; Kennedy, D. A.; Shustov, A. R. |
| Abstract Title: | Brentuximab vedotin in combination with CHP in patients (pts) with newly-diagnosed CD30+ peripheral T-cell lymphomas (PTCL): 2-year follow-up |
| Meeting Title: | 39th ESMO Congress (ESMO 2014) |
| Journal Title: | Annals of Oncology |
| Volume: | 25 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2014 Sep 26-30 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-09-01 |
| Start Page: | iv327 |
| Language: | English |
| ACCESSION: | WOS:000346901000272 |
| DOI: | 10.1093/annonc/mdu339.1 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 944O -- Source: Wos |
